Amit Madhaorao Pant

Dr. Amit Madhaorao Pant

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2023 in Bioorganic Chemistry
Verified
Journal Article
Closed access
RBRitesh P Bhole
Ritesh P Bhole
PKPayal R. Kute
Payal R. Kute
RCRupesh V Chikhale
Rupesh V Chikhale
CBC.G. Bonde
C.G. Bonde
APAmit Madhaorao Pant
Amit Madhaorao Pant
Shailendra Shivaji GuravShailendra Shivaji Gurav
Shailendra Shivaji Gurav

1 October 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
RCRupesh V Chikhale
Rupesh V Chikhale
STSonali Thorat
Sonali Thorat
APAmit Madhaorao Pant
Amit Madhaorao Pant
AJAnkush Jadhav
Ankush Jadhav
KTKrishna Chary Thatipamula
Krishna Chary Thatipamula
PKPramod Khedekar
Pramod Khedekar

1 July 2017 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
RCRupesh V Chikhale
Rupesh V Chikhale
APAmit Madhaorao Pant
Amit Madhaorao Pant
SMSunil S. Menghani
Sunil S. Menghani
PWPankaj G. Wadibhasme
Pankaj G. Wadibhasme
PKPramod B. Khedekar
Pramod B. Khedekar
A highly efficient, simple and rapid method for the preparation of various 2-aminobenzoxazoles and other benzoxazole derivatives using a catalytic amount of poly (ethylene glycol)-bound sulfonic acid (PEG-SO3H) is described. PEG-SO3H is found to be an economical and reusable catalyst with low catalytic loading. The percent yield was found to be satisfactory, experimental set up and purification of final products are facile and easy

Verified
Journal Article
Open access
PDF file
NTNeerja Trivedi
Neerja Trivedi
JBJitendra Diliprao Bhosale
Jitendra Diliprao Bhosale
APAmit Madhaorao Pant
Amit Madhaorao Pant
SSSonali Pradeep Suryawanshi
Sonali Pradeep Suryawanshi
PTPrerna Tiwari
Prerna Tiwari
GJGopal Jadhav
Gopal Jadhav
Triggering receptor expressed on myeloid cells-1 (TREM-1), a member of the immunoglobulin superfamily, plays a crucial role in amplifying inflammatory responses, thereby contributing to the pathogenesis and progression of various inflammatory diseases. This review presents a comprehensive analysis of the current understanding of TREM-1 signaling and its dysregulation in disease pathology. Additionally, it explores the prognostic significance of TREM-1 across a spectrum of conditions. Targeting TREM-1 signaling represents a promising therapeutic approach for managing a wide range of diseases, including cancer, neurodegenerative disorders, cardiovascular diseases, and other inflammation-driven conditions. Previous reviews on TREM-1 have largely focused on its immunological role across diverse disease conditions and selective peptide-based inhibitors targeting its signaling pathway. However, recent discoveries have identified small-molecule modulators of TREM-1 that offer new opportunities for therapeutic intervention. Incorporating these findings would provide a more comprehensive and updated perspective on TREM-1 biology, particularly regarding its molecular regulation, drug-target potential, and translational relevance in inflammatory and immune-mediated disorders. Advances in this field are expected to be driven by structure-based drug design, particularly in the development of TREM-1 inhibitors. However, further research is needed to elucidate the predictive value of TREM-1 alterations and to evaluate them in prospective human studies prior to clinical decision-making.

17 December 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
JNJoshua C. Nwabuife
Joshua C. Nwabuife
DHDaniel Hassan
Daniel Hassan
APAmit Madhaorao Pant
Amit Madhaorao Pant
NDNikita Devnarain
Nikita Devnarain
MGMohammed Ali Gafar
Mohammed Ali Gafar
TGThirumala Govender
Thirumala Govender

27 May 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
RCRupesh V Chikhale
Rupesh V Chikhale
APAmit Madhaorao Pant
Amit Madhaorao Pant
SMSunil S Menghani
Sunil S Menghani
PKPramod B Khedekar
Pramod B Khedekar